GSK to start construction work on Godollo plant in August
…created in 2020 as a result of this investment. In addition, the investment is intended to help global Infanrix/Boostrix/Synflorix supplies, as their ingredients will be produced in Hungary. GSK runs three divisions in Hungary and has been in business in the country for 22 years.
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)